These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1629518)

  • 1. The local lymph node assay: results of a final inter-laboratory validation under field conditions.
    Scholes EW; Basketter DA; Sarll AE; Kimber I; Evans CD; Miller K; Robbins MC; Harrison PT; Waite SJ
    J Appl Toxicol; 1992 Jun; 12(3):217-22. PubMed ID: 1629518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement.
    Omori T; Idehara K; Kojima H; Sozu T; Arima K; Goto H; Hanada T; Ikarashi Y; Inoda T; Kanazawa Y; Kosaka T; Maki E; Morimoto T; Shinoda S; Shinoda N; Takeyoshi M; Tanaka M; Uratani M; Usami M; Yamanaka A; Yoneda T; Yoshimura I; Yuasa A
    J Pharmacol Toxicol Methods; 2008; 58(1):11-26. PubMed ID: 18593646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation.
    Kojima H; Takeyoshi M; Sozu T; Awogi T; Arima K; Idehara K; Ikarashi Y; Kanazawa Y; Maki E; Omori T; Yuasa A; Yoshimura I
    J Appl Toxicol; 2011 Jan; 31(1):63-74. PubMed ID: 20677212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the local lymph node assay with the guinea-pig maximization test for the detection of a range of contact allergens.
    Basketter DA; Scholes EW
    Food Chem Toxicol; 1992 Jan; 30(1):65-9. PubMed ID: 1544608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: an interlaboratory evaluation.
    Kimber I; Hilton J; Dearman RJ; Gerberick GF; Ryan CA; Basketter DA; Lea L; House RV; Ladics GS; Loveless SE; Hastings KL
    J Toxicol Environ Health A; 1998 Apr; 53(7):563-79. PubMed ID: 9561969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsaturated fatty acids show clear elicitation responses in a modified local lymph node assay with an elicitation phase, and test positive in the direct peptide reactivity assay.
    Yamashita K; Shinoda S; Hagiwara S; Miyazaki H; Itagaki H
    J Toxicol Sci; 2015 Dec; 40(6):843-53. PubMed ID: 26558466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine local lymph node assay: results of an inter-laboratory trial.
    Kimber I; Hilton J; Botham PA; Basketter DA; Scholes EW; Miller K; Robbins MC; Harrison PT; Gray TJ; Waite SJ
    Toxicol Lett; 1991 Feb; 55(2):203-13. PubMed ID: 1998208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
    Kreiling R; Hollnagel HM; Hareng L; Eigler D; Lee MS; Griem P; Dreessen B; Kleber M; Albrecht A; Garcia C; Wendel A
    Food Chem Toxicol; 2008 Jun; 46(6):1896-904. PubMed ID: 18343554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
    Durand G; de Burlet G; Virat M; Nauman BD
    Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of contact sensitivity of four thiourea rubber accelerators: comparison of two mouse lymph node assays with the guinea pig maximization test.
    Ikarashi Y; Ohno K; Momma J; Tsuchiya T; Nakamura A
    Food Chem Toxicol; 1994 Nov; 32(11):1067-72. PubMed ID: 7959462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of LLNA:DAE: a new local lymph node assay that includes the elicitation phase, discriminates borderline-positive chemicals, and is useful for cross-sensitization testing.
    Yamashita K; Shinoda S; Hagiwara S; Itagaki H
    J Toxicol Sci; 2014 Feb; 39(1):147-61. PubMed ID: 24418719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
    Gerberick GF; Cruse LW; Ryan CA
    Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
    Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
    Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The local lymph node assay in practice: a current regulatory perspective.
    Cockshott A; Evans P; Ryan CA; Gerberick GF; Betts CJ; Dearman RJ; Kimber I; Basketter DA
    Hum Exp Toxicol; 2006 Jul; 25(7):387-94. PubMed ID: 16898167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
    Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
    Arancioglu S; Ulker OC; Karakaya A
    Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
    Roberts DW; Schultz TW; Api AM
    Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.